Literature DB >> 14156834

JAUNDICE DURING IMIPRAMINE TREATMENT.

P C HOAKEN.   

Abstract

Entities:  

Keywords:  DEPRESSION; IMIPRAMINE; JAUNDICE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14156834      PMCID： PMC1927207     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  The treatment of depressive conditions with imipramine (G 22355).

Authors:  H E LEHMANN; C H CAHN; R L DE VERTEUIL
Journal:  Can Psychiatr Assoc J       Date:  1958-10

2.  [Treatment of depressive states with special consideration of tofranil, a new antidepressant].

Authors:  P KIELHOLZ; R BATTEGAY
Journal:  Schweiz Med Wochenschr       Date:  1958-08-02

3.  Preliminary evaluation of tofranil in a combined in-patient and out-patient setting.

Authors:  S MALITZ; B WILKENS; H ESECOVER
Journal:  Can Psychiatr Assoc J       Date:  1959
  3 in total
  4 in total

1.  Irreversible protein binding of 14C-imipramine in rats in vivo.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1976-12-23       Impact factor: 5.153

2.  Further studies on the effect of imipramine and desipramine on uridine diphosphate.

Authors:  R F Piper; T Hargreaves
Journal:  Experientia       Date:  1975-02-15

3.  Hepatic sensitivity to imipramine.

Authors:  G A Weaver; D Pavlinac; J S Davis
Journal:  Am J Dig Dis       Date:  1977-06

4.  Carbamazepine-induced jaundice.

Authors:  I D Ramsay
Journal:  Br Med J       Date:  1967-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.